Abstract: The clinical evaluation section of the Core Assessment
Program for intracerebral Transplantations (CAPIT) for Parkinson's
disease (PD) was developed to standardize the clinical evaluation in
cell transplantation trials, but also has been used in other therapeutic
trials for PD. An important part of the CAPIT protocol is the
standardized timed tests of motor function. In a recent revision of
CAPIT, the Core Assessment Program for Surgical Interventional Therapies
in Parkinson's Disease (CAPSIT-PD), the timed tests have been
modified. There are some practical considerations that need attention
when timed tests are used. They should be performed under the same
circumstances with the patient in a defined condition and according to
the same instructions from one time to another. Also, the examiner
should not assist the patient, either directly or indirectly, by cueing.
In addition to quantification of motor function as an outcome measure in
therapeutic trials and other clinical research, timed tests also can be
used for determining dopaminegic responsiveness in differential
diagnosis of parkinsonism. Our experience is that timed tests are
valuable quantitative and objective measures in scientific as well as
clinical assessments of PD. Practical guidelines for and examples of
these areas of use are provided.
**********
Parkinson's disease (PD) is a chronic progressive condition
characterized by degeneration of dopaminergic neurons originating from
substantia nigra pars compacta and innervating the striatum (i.e., the
putamen and caudate nucleus). The result is a striatal dopamine
deficiency with an imbalance in the basal ganglia motor circuit and
dysfunctional cortical activation. This is believed to cause the
movement disorder of PD, characterized by progressive poverty and
slowness of movement (hypo- and bradykinesia, respectively), tremor, and
rigidity. (1,2) The underlying etiology of PD has, however, yet to be
identified.
Numerous clinical rating scales have been suggested for
quantification and assessment of disease progression and the efficacy of
therapeutic interventions. Of these, the Hoehn & Yahr staging, (16)
the Webster scale, (26) the Columbia scale, (7) and the Unified
Parkinson's Disease Rating Scale (UPDRS) (8) are the most widely
used to date. A general concern when using clinical rating scales is
their subjectivity; that is, the score is dependent not only on the
motor performance of the patient but also on the examiner's
interpretation thereof. More objective measures, such as the
Postural-Locomotor-Manual (PLM) test, (25) have been developed. A major
practical concern with such technical devices, however, is that they are
relatively expensive and their use may require special location,
equipment, and training.
The Core Assessment Program for Intracerebral Transplantations
(CAPIT) was published in 1992. (19) The purpose of CAPIT was to
establish international consensus on the assessment of PD patients
enrolled in clinical cell transplantation protocols, so that results
from different clinical trials could be compared and amalgamated. The
aim was to make CAPIT simple, accessible, and easy for anyone to use, as
well as comprehensive and objective. Since then, clinical assessment
according to CAPIT has gained widespread acceptance and been applied to
the assessment of patients not only in transplantation trials, but also
in trials of other therapeutic interventions for PD, such as pallidotomy
(3) and deep brain stimulation. (17) CAPIT includes recommendations for
clinical assessments, patient selection criteria, the graft tissue, and
brain imaging techniques.
The clinical assessment section comprises patient-derived
"on/off" diaries, observations during regular medication, and
single-dose levodopa drug challenges. The levodopa test includes
assessments in the practically defined "off" condition (i.e.,
in the morning, [greater than or equal to] 12 hours after the last
anti-parkinsonian medication and [greater than or equal to] 1 hour after
arising), in the best "on" condition, and continual (every 20
minutes) monitoring of motor performance following the intake of an
individually standardized single dose of levodopa (preferably equal to
the patient's first regular dose of the day), until the patient has
switched "off" again. These assessments are performed by means
of the UPDRS and timed motor tests. The timed tests can be considered a
more objective and quantitative complement to the motor examination
section of the UPDRS. The timed tests in CAPIT are pronation/supination
of the hands, finger dexterity, hand/arm movement between two points,
and a walking test.
The CAPIT protocol has recently been revised to make it more
suitable as a common assessment program for all neurosurgical
interventions in PD, not just transplantation trials. The revised
version is called the Core Assessment Program for Surgical
Interventional Therapies in Parkinson's Disease (CAPSIT-PD). (6)
Briefly, the revision comprises simplifications of the single-dose
levodopa drug challenge, omission of the clinical observations during
regular medication, and improved assessments of dyskinesias.
Furthermore, neuropsychological assessments and health-related
quality-of-life measures also have been added, and the "best
on" condition has been redefined as "defined on." Two of
the timed tests, pronation/supination of the hands and finger dexterity,
have been omitted and the other two have been modified.
As a practical complement to the CAPIT and CAPSIT-PD protocols,
(6,19) this article provides more detailed guidelines, recommendations,
and suggestions for the use of timed tests as complements to other
measures in the clinical assessment of motor function in PD. The
usefulness of these tests in clinical practice also is addressed.
Detailed instructions about other clinical motor assessments included in
the CAPIT and CAPSIT-PD protocols are available elsewhere. (11,12)
Timed Tests
Although the timed tests are an objective and quantitative method
of evaluation, there are some practical considerations that need
attention to make them as reliable and valuable as possible.
Instructions and practical considerations on how to perform the
respective tests are provided below. The hand/arm movement and walking
tests are described and discussed as they appear in the new CAPSIT-PD,
(6) whereas the pronation/supination and finger dexterity tests refer to
the original CAPIT protocol. (19)
* Pronation/supination of the hands is performed with the patient
sitting in a chair, tapping first the palm and then the back of his or
her hand against the ipsilateral thigh. When commencing the test, the
patient is instructed to rest the back of his or her hand on the thigh.
The time in seconds for 20 successive movement cycles, that is, tapping
of the palm and back of the hand, is recorded.
* Finger dexterity is performed with the patient seated in a chair.
The patient is asked to hold up his or her hand and tap his or her thumb
with each finger, starting with the index finger and back again. The
time in seconds for 10 successive movement cycles, that is, from the
index finger to the little finger and back again 10 times, is recorded.
* The hand/arm movement between two points is performed with the
patient seated in a chair with a table in front of him or her. The table
should be of comfortable height, preferably no more than 15 centimeters
above the patient's knees. The patient is asked to tap his or her
index finger back and forth, laterally, between two points placed 30
centimeters apart on the table. The number of completed movement cycles,
that is, moving the finger from point one, tapping the second point and
moving it back to point one again, during 20 seconds is recorded.
* In the walking test, the patient is asked to walk 7 meters, turn
around and walk back again. The number of steps, including turning
around, and time in seconds are recorded. If freezing episodes occur,
these should also be counted and recorded.
Practical Considerations
Motor performance in PD is often influenced by factors such as
stress and environment. Therefore, in order to yield comparable results,
tests must be performed under the same circumstances on each occasion
and from one patient to another. The location and surroundings should be
as calm as possible and the same or similar from one occasion to
another. To allow firm interpretation of the results, tests must be
performed during defined conditions (e.g., practically defined
"off" and "on") or time points in relation to drug
intake, using the same set of tests performed the same way at each
occasion. If more than one examiner is conducting the tests, it is
important to make sure that each one is performing them the same way. As
always when assessing movement disorders, it is also advantageous to
videotape the test sessions.
COPYRIGHT 2000 American Association of Neuroscience
Nurses Reproduced with permission of the copyright holder. Further reproduction or distribution is prohibited without permission.
Copyright 2000, Gale Group. All rights
reserved. Gale Group is a Thomson Corporation Company.
NOTE: All illustrations and photos have been removed from this article.